Biodexa Pharmaceuticals PLC — Form 6-K
Reporting context: The company furnished this Form 6-K on October 14, 2026, for October 2026. It identifies an accompanying press release dated October 13, 2026 (Exhibit 99.1), but the press release text is not included in the supplied filing content.
Financial and operating information
The supplied text does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, guidance, or other operating metrics. It also does not provide a clear comparison with a prior period.
Disclosure and investor checks
- The company reports under Form 20-F.
- The filing states that the furnished information is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless specifically referenced.
- Investors should verify the full October 13, 2026 press release (Exhibit 99.1) for any material business updates, financial information, outlook, risks, or contingencies; these details are not present in the supplied text.